Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Clinical Research Center of Cape Cod has agreed to collect and provide lung sputum samples necessary for Biomoda's commercialization program of its non-invasive sputum assay for the early detection of lung cancer.
Subscribe to our email newsletter
The Clinical Research Center of Cape Cod (CRCCC) is a medical research firm with products and services that support the pharmaceutical, biotechnology, diagnostic and genomics industries.
John Cousins, president of Biomoda, said: “CRCCC will deliver quality, state-of-the-art services to help us bring our products to the market. We are aggressively pursuing internal studies that, coupled with our clinical work with other organizations, will make our assay available to the public in the short term. CRCCC will help make that happen by supplying quality samples in a timely manner.”
Financial details were not disclosed.